Journal ArticleDOI
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
Ernst-Ruediger Kuse,Ploenchan Chetchotisakd,Clovis Arns da Cunha,Markus Ruhnke,Carlos H. Barrios,D Raghunadharao,Jagdev Singh Sekhon,Antonio Freire,V Ramasubramanian,Ignace Demeyer,Marcio Nucci,Amorn Leelarasamee,Frédérique Jacobs,Johan Decruyenaere,Didier Pittet,Andrew J. Ullmann,Luis Ostrosky-Zeichner,Olivier Lortholary,Sonja Koblinger,Heike Diekmann-Berndt,Oliver A. Cornely +20 more
Reads0
Chats0
TLDR
Micafungin was as effective as--and caused fewer adverse events than--liposomal amphotericin B as first-line treatment of candidaemia and invasive candidosis.About:
This article is published in The Lancet.The article was published on 2007-05-05. It has received 630 citations till now. The article focuses on the topics: Micafungin & Amphotericin B.read more
Citations
More filters
Journal ArticleDOI
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
Peter G. Pappas,Carol A. Kauffman,David R. Andes,Daniel K. Benjamin,Thierry Calandra,John E. Edwards,Scott G. Filler,John F. Fisher,Bart Jan Kullberg,Luis Ostrosky-Zeichner,Annette C. Reboli,John H. Rex,Thomas J. Walsh,Jack D. Sobel +13 more
TL;DR: These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections.
Journal ArticleDOI
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
Leonard A. Mermel,Michael Allon,Emilio Bouza,Donald E. Craven,Patricia M. Flynn,Issam I Raad,Bart J. A. Rijnders,Robert J. Sherertz,David K. Warren,North Carolina +9 more
TL;DR: These updated guidelines replace the previous management guidelines published in 2001 and are intended for use by health care providers who care for patients who either have these infections or may be at risk for them.
Journal ArticleDOI
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas,Carol A. Kauffman,David R. Andes,Cornelius J. Clancy,Kieren A. Marr,Luis Ostrosky-Zeichner,Annette C. Reboli,Mindy G. Schuster,Jose A. Vazquez,Thomas J. Walsh,Theoklis E. Zaoutis,Jack D. Sobel +11 more
TL;DR: IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.
Journal ArticleDOI
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
Oliver A. Cornely,Matteo Bassetti,Thierry Calandra,Jorge Garbino,Bart Jan Kullberg,O. Lortholary,O. Lortholary,Wouter Meersseman,Murat Akova,Maiken Cavling Arendrup,S. Arikan-Akdagli,Jacques Bille,Elio Castagnola,Manuel Cuenca-Estrella,J.P. Donnelly,Andreas H. Groll,Raoul Herbrecht,William W. Hope,Henrik Jeldtoft Jensen,Cornelia Lass-Flörl,George Petrikkos,Malcolm Richardson,Emmanuel Roilides,Paul E. Verweij,Claudio Viscoli,Andrew J. Ullmann +25 more
TL;DR: This part of the EFISG guidelines focuses on non-neutropenic adult patients, and liposomal amphotericin B and voriconazole are supported with moderate, and fluconazole with marginal strength for the targeted initial treatment of candidaemia.
Journal ArticleDOI
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials
David R. Andes,Nasia Safdar,John W. Baddley,Geoffrey Playford,Annette C. Reboli,John H. Rex,Jack D. Sobel,Peter G. Pappas,Bart Jan Kullberg +8 more
TL;DR: Two treatment-related factors were associated with improved survival and greater clinical success: use of an echinocandin and removal of the CVC.
References
More filters
Journal ArticleDOI
The Use of Plasma Creatinine Concentration for Estimating Glomerular Filtration Rate in Infants, Children, and Adolescents
TL;DR: The formula GFR = kL/Pcr can be used to estimate GFR in infants, children, and adolescents who have grossly normal body habitus and are in steady-state condition and the advantages of rapid determination, reasonable accuracy, and the avoidance of urine collection justify the use of this formula in pediatric patients.
Journal ArticleDOI
Guidelines for Treatment of Candidiasis
Peter G. Pappas,John H. Rex,Jack D. Sobel,Scott G. Filler,William E. Dismukes,Thomas J. Walsh,John E. Edwards +6 more
TL;DR: This work presents a novel and scalable approach that allows for real-time decision-making about whether or not to vaccinate children against infection by a single infectious agent.
Journal ArticleDOI
Comparison of caspofungin and amphotericin B for invasive candidiasis.
Jorge Mora-Duarte,Robert F. Betts,Coleman Rotstein,Arnaldo Lopes Colombo,Luis Thompson-Moya,Juanita M Smietana,Robert J. Lupinacci,Carole A. Sable,Nicholas A. Kartsonis,John R. Perfect +9 more
TL;DR: Caspofungin is at least as effective as amphotericin B for the treatment of invasive candidiasis and, more specifically, candidemia.
Journal ArticleDOI
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Thomas J. Walsh,Robert W. Finberg,Carola A.S. Arndt,John W. Hiemenz,Cindy L. Schwartz,David C. Bodensteiner,Peter G. Pappas,Nita Seibel,Richard N. Greenberg,Stephen Dummer,Mindy G. Schuster,John S. Holcenberg,William E. Dismukes +12 more
TL;DR: A randomized, double-blind, multicenter trial comparing liposomal amphotericin B with conventional amphoteric in B as empirical antifungal therapy for patients with persistent fever and neutropenia.
Journal ArticleDOI
Echinocandin antifungal drugs
TL;DR: Results of studies of caspofungin in candidaemia and invasive candidiasis suggest equivalent efficacy to amphotericin B, with substantially fewer toxic effects, suggests that combination antifungal therapy could become a general feature of the echinocandins.
Related Papers (5)
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Raoul Herbrecht,David W. Denning,David W. Denning,Thomas F. Patterson,John E. Bennett,Reginald Greene,Reginald Greene,J. W. Oestmann,Winfried V. Kern,Winfried V. Kern,Winfried V. Kern,Kieren A. Marr,Patricia Ribaud,Olivier Lortholary,Richard J. Sylvester,Robert H. Rubin,John R. Wingard,Paul Stark,Christine Durand,Denis Caillot,Eckhard Thiel,Pranatharthi H. Chandrasekar,Michael R. Hodges,Haran T. Schlamm,Peter F. Troke,Ben E. De Pauw +25 more